PubRank

Alicja Wegrzyn

Author PubWeight™ 30.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 2006 1.41
2 Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathog 2009 1.18
3 Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism. Microb Cell Fact 2006 1.12
4 Leptospirosis vaccines. Microb Cell Fact 2007 1.11
5 Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunol Med Microbiol 2009 1.09
6 Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions. Appl Environ Microbiol 2008 1.07
7 Genetic switches during bacteriophage lambda development. Prog Nucleic Acid Res Mol Biol 2005 1.00
8 Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. J Appl Genet 2007 0.98
9 Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatr 2008 0.92
10 Effective inhibition of lytic development of bacteriophages lambda, P1 and T4 by starvation of their host, Escherichia coli. BMC Biotechnol 2007 0.92
11 Bacteriophage contamination: is there a simple method to reduce its deleterious effects in laboratory cultures and biotechnological factories? J Appl Genet 2004 0.91
12 Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 2011 0.91
13 Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem Soc Trans 2010 0.90
14 Stress responses and replication of plasmids in bacterial cells. Microb Cell Fact 2002 0.90
15 Plasmids derived from lambdoid bacteriophages as models for studying replication of mobile genetic elements responsible for the production of Shiga toxins by pathogenic Escherichia coli strains. J Mol Microbiol Biotechnol 2009 0.89
16 SeqA-mediated stimulation of a promoter activity by facilitating functions of a transcription activator. Mol Microbiol 2003 0.88
17 DNA replication defect in the Escherichia coli cgtA(ts) mutant arising from reduced DnaA levels. Arch Microbiol 2006 0.86
18 Influence of the Escherichia coli oxyR gene function on lambda prophage maintenance. Arch Microbiol 2010 0.86
19 Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. Eur J Pediatr 2007 0.85
20 Inhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvation. Foodborne Pathog Dis 2011 0.84
21 Is tRNA only a translation factor or also a regulator of other processes? J Appl Genet 2008 0.84
22 Interplay between DnaA and SeqA proteins during regulation of bacteriophage lambda pR promoter activity. J Mol Biol 2003 0.81
23 Composition of the lambda plasmid heritable replication complex. Biochem J 2002 0.80
24 Mechanisms of physiological regulation of RNA synthesis in bacteria: new discoveries breaking old schemes. J Appl Genet 2007 0.80
25 Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme). Am J Med Genet A 2005 0.80
26 Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy. Am J Med Genet A 2007 0.80
27 Modulation of lambda plasmid and phage DNA replication by Escherichia coli SeqA protein. Microbiology 2007 0.79
28 Switch from theta to sigma replication of bacteriophage lambda DNA: factors involved in the process and a model for its regulation. Mol Genet Genomics 2007 0.79
29 A bacterial model for studying effects of human mutations in vivo: Escherichia coli strains mimicking a common polymorphism in the human MTHFR gene. Mutat Res 2005 0.78
30 Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study. BMC Pediatr 2005 0.78
31 Transcription regulation of the Escherichia coli pcnB gene coding for poly(A) polymerase I: roles of ppGpp, DksA and sigma factors. Mol Genet Genomics 2010 0.78
32 Stimulation of the lambda pR promoter by Escherichia coli SeqA protein requires downstream GATC sequences and involves late stages of transcription initiation. Microbiology 2006 0.77
33 Non-random distribution of GATC sequences in regions of promoters stimulated by the SeqA protein of Escherichia coli. Acta Biochim Pol 2003 0.76
34 A novel method for screening the glutathione transferase inhibitors. BMC Biochem 2009 0.75
35 [Bacteriophage lambda DNA replication--new discoveries made using an old experimental model]. Postepy Biochem 2006 0.75
36 Classification of plasmid vectors using replication origin, selection marker and promoter as criteria. Plasmid 2008 0.75
37 Screening of the osmotic pressure-inducible promoter regions from the whole genome of Escherichia coli by using a novel cloning method. Biotechnol Lett 2007 0.75